Table 1.
Antibodies used in the study.
| Antibody | Manufacturer | Identifier |
|---|---|---|
| CD45 BUV395-A | Becton, Dickinson and Company | Cat#564279 |
| CD11b BB515-A | Becton, Dickinson and Company | Cat#557397 |
| BV421 F4/80-A | Becton, Dickinson and Company | Cat#564088 |
| CD3 APC-Alexa 700-A | Becton, Dickinson and Company | Cat#561388 |
| CD8 BUV805-A | Becton, Dickinson and Company | Cat#612898 |
| CD25 BB700-A | Becton, Dickinson and Company | Cat#567482 |
| CD20 PE-BYG568-A | Becton, Dickinson and Company | Cat#152106 |
| NK1-1 PE-CF594-A | Becton, Dickinson and Company | Cat#562864 |
| CD69 BV711-A | Becton, Dickinson and Company | Cat#740664 |
| Fixable Viability Stain 780 | Becton, Dickinson and Company | Cat#565388 |
| NF-κB | ABclonal | A19653 |
| p-NF-κB | ABclonal | AP0475 |
| GAPDH | ABclonal | A19056 |
| β-actin | Servucebio | GB15001-100 |
| IKBα | Cell Signaling Technology | Cat#48125 |
| p-IKBα | Cell Signaling Technology | Cat#2859T |